Michael Hotchkiss, MD
Obstetrics & Gynecology · Waldorf, MDNPI 1326116401
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $6,466 of the $6,825 with a category attached, or 94.7%. KARL Storz Endoscopy-america accounts for 94.7% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2020 at $6,531 and has fallen 99.6% since, to $29 in 2023. Among obstetrics & gynecology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 47 payments — averaging $145.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- KARL Storz Endoscopy-america$6K
- Duchesnay USA Incorporated$137
- Therapeuticsmd, Inc.$44
- Organon$23
- Hologic Sales And Service, LLC$21
- AMAG Pharmaceuticals, Inc.$18
- plus $116 from 8 others
What the payments were for
- Food & beverage$3205%
- Education$391%
- Gifts$6,46695%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| KARL Storz Endoscopy-america | 31 | $6,466 |
| Duchesnay USA Incorporated | 3 | $137 |
| Therapeuticsmd, Inc. | 2 | $44 |
| Organon | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $21 |
| AMAG Pharmaceuticals, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Myovant Sciences Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| AbbVie | 1 | $15 |
| Pfizer | 1 | $14 |
| Coopersurgical, Inc. | 1 | $13 |
| Bayer | 1 | $13 |
| Dysis Medical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Osphena$109
How this compares
$6,825 in reported general payments places this provider in the 95th percentile of 842 obstetrics & gynecology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 56 | $4,184 |
| Clobetasol Propionate | 19 | $866 |
| ValacyclovirValacyclovir Hcl | 15 | $437 |
| Nystatin | 11 | $144 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Waldorf
- Otis StittSilver Spring$641K
- Danielle ShillerBaltimore$221K
- Matthew ReevesChevy Chase$149K
- Karen WangBaltimore$91K
- Rebecca StoneBaltimore$88K
- Abigail GregoryOakland$63K
- Christina EnzmannBaltimore$63K
- Lisa RarickChesapeake Beach$54K
- Logan PetersonBethesda$52K
- Latasha MurphyBaltimore$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.